Short-term Testosterone Replacement in Testicular Cancer Survivors
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
To assess the effects of testosterone replacement therapy on fat mass and other components of
the metabolic syndrome. A randomized double-blind placebo controlled intervention study,
followed by an open-label treatment phase. Results of this pilot study will be used to design
a multicenter randomized controlled study in a large group of TC survivors